Matches in DBpedia 2016-04 for { <http://citation.dbpedia.org/hash/65fc777cba69516eca3c0e12cb49352b49eeea6e4ea2e8f3f8741cc3c0ba5d2e> ?p ?o }
Showing triples 1 to 8 of
8
with 100 triples per page.
- 65fc777cba69516eca3c0e12cb49352b49eeea6e4ea2e8f3f8741cc3c0ba5d2e author "Ruilope LM, Redón J, Schmieder R".
- 65fc777cba69516eca3c0e12cb49352b49eeea6e4ea2e8f3f8741cc3c0ba5d2e isCitedBy Endothelial_dysfunction.
- 65fc777cba69516eca3c0e12cb49352b49eeea6e4ea2e8f3f8741cc3c0ba5d2e issue "1".
- 65fc777cba69516eca3c0e12cb49352b49eeea6e4ea2e8f3f8741cc3c0ba5d2e journal "Vasc Health Risk Manag".
- 65fc777cba69516eca3c0e12cb49352b49eeea6e4ea2e8f3f8741cc3c0ba5d2e pages "1–9".
- 65fc777cba69516eca3c0e12cb49352b49eeea6e4ea2e8f3f8741cc3c0ba5d2e title "Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial Programme".
- 65fc777cba69516eca3c0e12cb49352b49eeea6e4ea2e8f3f8741cc3c0ba5d2e volume "3".
- 65fc777cba69516eca3c0e12cb49352b49eeea6e4ea2e8f3f8741cc3c0ba5d2e year "2007".